1. Home
  2. GLAD vs TMCI Comparison

GLAD vs TMCI Comparison

Compare GLAD & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLAD
  • TMCI
  • Stock Information
  • Founded
  • GLAD 2001
  • TMCI 2014
  • Country
  • GLAD United States
  • TMCI United States
  • Employees
  • GLAD N/A
  • TMCI N/A
  • Industry
  • GLAD Finance/Investors Services
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GLAD Finance
  • TMCI Health Care
  • Exchange
  • GLAD Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • GLAD 482.1M
  • TMCI 401.8M
  • IPO Year
  • GLAD N/A
  • TMCI 2021
  • Fundamental
  • Price
  • GLAD $19.24
  • TMCI $6.10
  • Analyst Decision
  • GLAD Hold
  • TMCI Hold
  • Analyst Count
  • GLAD 2
  • TMCI 5
  • Target Price
  • GLAD $25.75
  • TMCI $8.40
  • AVG Volume (30 Days)
  • GLAD 290.6K
  • TMCI 222.7K
  • Earning Date
  • GLAD 11-17-2025
  • TMCI 11-06-2025
  • Dividend Yield
  • GLAD 10.85%
  • TMCI N/A
  • EPS Growth
  • GLAD N/A
  • TMCI N/A
  • EPS
  • GLAD 3.38
  • TMCI N/A
  • Revenue
  • GLAD $88,900,000.00
  • TMCI $213,751,000.00
  • Revenue This Year
  • GLAD N/A
  • TMCI $10.63
  • Revenue Next Year
  • GLAD $16.05
  • TMCI $9.43
  • P/E Ratio
  • GLAD $5.68
  • TMCI N/A
  • Revenue Growth
  • GLAD N/A
  • TMCI 7.67
  • 52 Week Low
  • GLAD $18.90
  • TMCI $4.70
  • 52 Week High
  • GLAD $30.43
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • GLAD 32.84
  • TMCI 38.23
  • Support Level
  • GLAD $19.00
  • TMCI $6.23
  • Resistance Level
  • GLAD $19.51
  • TMCI $6.65
  • Average True Range (ATR)
  • GLAD 0.44
  • TMCI 0.28
  • MACD
  • GLAD 0.14
  • TMCI -0.03
  • Stochastic Oscillator
  • GLAD 30.41
  • TMCI 1.96

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: